Patent · US Active

Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases

US8404675B2 · kind B2 · utility

0Cited by
41References
94Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 22, 2010
Grant dateMar 26, 2013
Priority date
Expiry dateSep 1, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D223/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.